---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-004721"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T02:24:00.377684+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# VolitionRx shareholders approve authorized share increase to 325M; all director nominees elected

## Summary
- Authorized common shares increased from 175M to 325M effective June 18, 2025, via Certificate of Second Amendment.
- All eight director nominees elected with ~35-36M votes for each; about 14.7M broker non-votes.
- Ratification of Sadler, Gibb & Associates as auditor passed with 51.3M votes for, 330k against.
- Non-binding advisory vote on named executive officer compensation passed with 34.4M for, 2.3M against.
- Charter amendment proposal passed with 49.5M votes for, 1.8M against, and 385k abstentions.

## SEC filing metadata
- accession: 0001477932-25-004721
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793225004721/0001477932-25-004721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793225004721/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-004721
- JSON: https://secwatch.observer/filing/0001477932-25-004721.json
- Plain text: https://secwatch.observer/filing/0001477932-25-004721.txt

## Key facts
- Governance Changes
  VOLITIONRX LTD: Increased authorized shares from 175 million to 325 million via amendment to certificate of incorporation (effective 2025-06-18).
  - Change: charter amendment
  - Effective: 2025-06-18
  source text: On June 18, 2025, VolitionRx Limited (the " Company ") held its annual meeting of stockholders (the " Annual Meeting "). At the Annual Meeting, the Company’s stockholders approved a Certificate of Second Amendment (the " Amendment ") of the Second Amended and Restated Certificate of Incorporation (the " Restated Certificate "), providing for an increase in authorized shares from one hundred seventy-five million (175,000,000) shares to three hundred twenty-five million (325,000,000) shares, consisting of three hundred twenty-five million (325,000,000) shares of common stock, par value $0.001 per share. The Amendment had previously been approved by the Board of Directors on April 2, 2025, subject to the approval of the Company’s Stockholders. The Amendment became effective upon its filing with the Secretary of State of the State of Delaware on June 18, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793225004721/0001477932-25-004721-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.